Granza Bio
ActiveBuilding programmable therapeutics for the immune system
What it does
Granza Bio is developing programmable therapeutics for the immune system. Our platform is built on the foundational discovery of immune “superkiller” attack particles — the natural ammunition used by cytotoxic immune cells to deliver potent, localized killing. By re-arming exhausted immune cells with newly programmed ammunition, Granza restores and enhances immune function. This approach enables a new class of treatments with the potential to transform diseases ranging from cancer to autoimmunity.
Its site says now · captured 2026-08-23
Granza Bio
Reprogramming Immunity for Target-Specific Medicines
Next to it in Healthcare and bio · programmable immunotherapy platform
- Kopra BioY Combinator S24
Genetically engineered viruses that teach your immune system to kill…
- Adventris PharmaceuticalsY Combinator W23
Adventris makes cancer vaccines
- Guardian BioY Combinator S22
Dendritic cell-based platform for cancer therapy
- Scioto BiosciencesPlug and Play PnP 2025
Scioto is a preclinical stage company developing innovative therapies devoted to having a transformative impact.
- Engage BioY Combinator W22
Potent, durable, and redosable non-viral genetic medicines
- FinalDoseY Combinator X26
Programmable DNA drug destroying all cancers, unlocking 80% of targets
- OmantaY Combinator S26
A research lab for one
- OpenBiomeY Combinator W20
A nonprofit stool bank enabling access to fecal transplants.